| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV-VIROLOGY-101416-041646 |
| P698 | PubMed publication ID | 28715973 |
| P2093 | author name string | Jonathan Karn | |
| Uri Mbonye | |||
| P577 | publication date | 2017-07-17 | |
| P1433 | published in | Annual Review of Virology | Q19962702 |
| P1476 | title | The Molecular Basis for Human Immunodeficiency Virus Latency |
| Q90545813 | Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection |
| Q90594756 | Barriers for HIV Cure: The Latent Reservoir |
| Q92637590 | Block-And-Lock Strategies to Cure HIV Infection |
| Q59359728 | CD4 T Cell Subsets and Pathways to HIV Latency |
| Q90633999 | CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models |
| Q96350898 | Conditional expression of HIV-1 Tat in the mouse alters the onset and progression of tonic, inflammatory, and neuropathic hypersensitivity in a sex-dependent manner |
| Q54216878 | Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation. |
| Q90683506 | Diversity of small molecule HIV-1 latency reversing agents identified in low- and high-throughput small molecule screens |
| Q99713341 | Effect of Opioid Use on Immune Activation and HIV Persistence on ART |
| Q91617582 | Effect of transcription inhibition and generation of suppressive viral non-coding RNAs |
| Q64120094 | Entry of Polarized Effector Cells into Quiescence Forces HIV Latency |
| Q89669108 | Epigenetic crosstalk in chronic infection with HIV-1 |
| Q93020476 | Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation |
| Q99589538 | Genome-wide CRISPR knockout screen identifies ZNF304 as a silencer of HIV transcription that promotes viral latency |
| Q47555333 | Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV. |
| Q98772201 | Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency |
| Q90221085 | HIV-1 Tat: Role in Bystander Toxicity |
| Q64095452 | HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells |
| Q47563715 | HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency |
| Q91806510 | Heavy metal protease takes a tiki torch to HIV assembly |
| Q64100189 | Hexamethylene bisacetamide impairs NK cell-mediated clearance of acute T lymphoblastic leukemia cells and HIV-1-infected T cells that exit viral latency |
| Q91644479 | Idiosyncrasies of Viral Noncoding RNAs Provide Insights into Host Cell Biology |
| Q90458215 | Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy |
| Q57042525 | Lymphatic endothelial cells promote productive and latent HIV infection in resting CD4+ T cells |
| Q64985976 | Mechanisms of HIV-1 cell-to-cell transmission and the establishment of the latent reservoir. |
| Q57050517 | Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway |
| Q47551768 | NF-κB-Chromatin Interactions Drive Diverse Phenotypes by Modulating Transcriptional Noise |
| Q89782162 | P-TEFb as A Promising Therapeutic Target |
| Q98292027 | Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease |
| Q64259746 | Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells |
| Q58099445 | Roles of CDKs in RNA Polymerase II Transcription of the HIV-1 Genome |
| Q55285065 | SHMT2 and the BRCC36/BRISC deubiquitinase regulate HIV-1 Tat K63-ubiquitylation and destruction by autophagy. |
| Q47556373 | Single-molecule techniques to quantify and genetically characterise persistent HIV. |
| Q90483462 | Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis |
| Q92300043 | Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs |
| Q61814094 | TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb |
| Q90292108 | Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression |
| Q64107839 | Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat |
| Q59357362 | The Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells |
| Q52312695 | The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency. |
Search more.